Arcana Arzneimittel

Arcana Arzneimittel is a German pharmaceutical company specializing in the development and distribution of generic medications. Based in Bad Homburg, the company provides a wide portfolio of affordable, high-quality drugs across various therapeutic areas, including cardiovascular health, neurology, and pain management. Originally founded in 1958, Arcana became part of the Mylan group in 2007 following Mylan's acquisition of Merck KGaA's generics division. Today, it operates as a key commercial subsidiary of Viatris, the global healthcare company formed by the 2020 merger of Mylan and Pfizer's Upjohn business. Arcana remains a significant player in the German generics market, focusing on ensuring patient access to essential off-patent medicines.